SA

Shresth Agrawal

Active Director Director DIN 11306261
DIN 11306261 First appointment Sep 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shresth Agrawal

Data last updated:

Shresth Agrawal is a Director at Medastra Medical Technologies Private Limited (since 2025).

DIN 11306261
Primary Designation Director
First Appointment 18 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Sep 20252025Active

Board colleagues of Shresth Agrawal

NameDINCompanyDesignation
Seema Agarwal11306262Medastra Medical Technologies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medastra Medical Technologies Private Limited
Premium access

Shareholding and investment profile for Shresth Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shresth Agrawal

Shresth Agrawal currently holds 1 directorship: Medastra Medical Technologies Private Limited (Director, since 18 Sep 2025).

Shresth Agrawal was first appointed on 18 Sep 2025 as Director at Medastra Medical Technologies Private Limited.

The current boards of Shresth Agrawal's companies include Seema Agarwal (Medastra Medical Technologies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available